Besplatna dostava Overseas kurirskom službom iznad 59.99 €
Overseas 4.99 Pošta 4.99 DPD 5.99 GLS 3.99 GLS paketomat 3.49 Box Now 4.49

Besplatna dostava putem Box Now paketomata i Overseas kurirske službe iznad 59,99 €!

Merger of Sanofi-Synthelabo and Aventis

Jezik EngleskiEngleski
Knjiga Meki uvez
Knjiga Merger of Sanofi-Synthelabo and Aventis Juliane Kuballa
Libristo kod: 01597291
Nakladnici Grin Publishing, studeni 2007
Seminar paper from the year 2006 in the subject Business economics - Investment and Finance, printed... Cijeli opis
? points 102 b
40.73
Vanjske zalihe Šaljemo za 15-20 dana

30 dana za povrat kupljenih proizvoda


Moglo bi vas zanimati i


FC Wacker Innsbruck Georg Herrmann / Tvrdi uvez
common.buy 20.72
Freiheit, Kreativität, Gemeinschaft Gerhard Wegner / Meki uvez
common.buy 21.73
Ancient Synagogue Seating Capacities Chad S. Spigel / Tvrdi uvez
common.buy 235.85
GER-LEBEN HORACE GREELEYS James 1822-1891 Parton / Tvrdi uvez
common.buy 32.75
Judentum in Richard Wagners Ring des Nibelungen Michael Günther / Meki uvez
common.buy 61.86
Gewürze Bettina Matthaei / Meki uvez
common.buy 12.93
BILD MACHT SCHRIFT Antonio Loprieno / Tvrdi uvez
common.buy 30.52

Seminar paper from the year 2006 in the subject Business economics - Investment and Finance, printed single-sided, grade: 80, Northumbria University (Newcastle Northumbria University), 47 entries in the bibliography, language: English, abstract: In the first part, this academic assignment provides general information about motives for international acquisitions. Moreover, it discusses whether foreign exchange markets and stock markets can be said to be efficient. The second part critically analyses the Merger of Sanofi-Synthélabo and Aventis by examining the following aspects:- market position of each company prior to the merger - motives for the proposed merger - attack and defence tactics applied by Sanofi-Synthélabo and Aventis - methods used to finance the merger- share price movements immediately before during and after the proposed take-over (commenting on the benefits to shareholders of each company)- company performance in the period following the take-over (reflecting on the initial take-over motives)

Informacije o knjizi

Puni naziv Merger of Sanofi-Synthelabo and Aventis
Jezik Engleski
Uvez Knjiga - Meki uvez
Datum izdanja 2007
Broj stranica 72
EAN 9783638727211
ISBN 3638727211
Libristo kod 01597291
Nakladnici Grin Publishing
Težina 104
Dimenzije 148 x 210 x 4
Poklonite ovu knjigu još danas
To je jednostavno
1 Dodajte knjigu u košaricu i odaberite isporuku kao poklon 2 Zauzvrat ćemo vam poslati kupon 3 Knjiga dolazi na adresu poklonoprimca

Prijava

Prijavite se na svoj račun. Još nemate Libristo račun? Otvorite ga odmah!

 
obvezno
obvezno

Nemate račun? Ostvarite pogodnosti uz Libristo račun!

Sve ćete imati pod kontrolom uz Libristo račun.

Otvoriti Libristo račun